Literature DB >> 8212197

Experimental graft arteriosclerosis. II. Immunocytochemical analysis of lesion development.

D H Adams1, L R Wyner, M J Karnovsky.   

Abstract

The development of progressive graft arteriosclerosis causes the majority of late deaths occurring in cardiac transplant recipients. The pathogenesis of this process remains unclear. In order to characterize the cellular composition of lesions progressively, we employed a model of graft arteriosclerosis in the rat involving untreated heterotopic cardiac allografts transplanted across minor histocompatibility barriers. Immunocytochemical studies were performed on arterial lesions in allografts removed at 15, 45, 75, and 120 days posttransplantation, using monoclonal antibodies specific for smooth muscle cells (HHF35, CGA7), monocytes/macrophages (ED1), T cells (W313), and endothelial cells (anti-vWf). We found areas of coronary intimal thickening demonstrated marked cellular heterogeneity. The earliest lesions involved the adherence of monocytes and T cells to the coronary endothelial surface. At later time points, we noted marked subendothelial accumulations of macrophages and occasional T cells in areas of intimal thickening. In contrast, smooth muscle cells were the major cell type identified in intimal lesions in 120-day-old allografts. Intimal macrophages are frequently seen in spontaneous human arteriosclerotic lesions; our findings suggest that macrophages, perhaps interacting with T cells, play an important role in the pathogenesis of graft arteriosclerosis.

Entities:  

Mesh:

Year:  1993        PMID: 8212197     DOI: 10.1097/00007890-199310000-00004

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  10 in total

Review 1.  Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.

Authors:  A J Demetris; N Murase; R G Lee; P Randhawa; A Zeevi; S Pham; R Duquesnoy; J J Fung; T E Starzl
Journal:  Ann Transplant       Date:  1997       Impact factor: 1.530

2.  Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-gamma knockout recipients.

Authors:  A Räisänen-Sokolowski; T Glysing-Jensen; J Koglin; M E Russell
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

3.  Chronic cardiac rejection: identification of five upregulated genes in transplanted hearts by differential mRNA display.

Authors:  U Utans; P Liang; L R Wyner; M J Karnovsky; M E Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

Review 4.  Morphology and immunohistochemistry of rat aortic grafts.

Authors:  P Rossmann; J Lácha; A Lodererová
Journal:  Folia Microbiol (Praha)       Date:  1999       Impact factor: 2.099

5.  Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection.

Authors:  N Ichikawa; A J Demetris; T E Starzl; Q Ye; T Okuda; H J Chun; K Liu; Y M Kim; N Murase
Journal:  Liver Transpl       Date:  2000-11       Impact factor: 5.799

6.  Identification and upregulation of galactose/N-acetylgalactosamine macrophage lectin in rat cardiac allografts with arteriosclerosis.

Authors:  M E Russell; U Utans; A F Wallace; P Liang; R J Arceci; M J Karnovsky; L R Wyner; Y Yamashita; C Tarn
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

7.  Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection.

Authors:  U Utans; R J Arceci; Y Yamashita; M E Russell
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

8.  Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis.

Authors:  M E Russell; W W Hancock; E Akalin; A F Wallace; T Glysing-Jensen; T A Willett; M H Sayegh
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

9.  Up-regulation of endothelin-1 mRNA and peptide expression in rat cardiac allografts with rejection and arteriosclerosis.

Authors:  B Watschinger; M H Sayegh; W W Hancock; M E Russell
Journal:  Am J Pathol       Date:  1995-05       Impact factor: 4.307

10.  Interleukin-5 (IL-5) Therapy Prevents Allograft Rejection by Promoting CD4+CD25+ Ts2 Regulatory Cells That Are Antigen-Specific and Express IL-5 Receptor.

Authors:  Bruce M Hall; Rachael M Hall; Giang T Tran; Catherine M Robinson; Paul L Wilcox; Prateek K Rakesh; Chuanmin Wang; Alexandra F Sharland; Nirupama D Verma; Suzanne J Hodgkinson
Journal:  Front Immunol       Date:  2021-11-29       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.